SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Filings re: Registrant of ‘10-Q’ Filing 1615774-19-7324


        

527  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   13   14   15   ...   27   ·  All     
Bottom



        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
  5/9/24  Anavex Life Sciences Corp.        10-Q        3/31/24   43:3.2M                                   Electro Filings LLC/FA   
  5/9/24  Anavex Life Sciences Corp.        8-K:2,9      5/9/24   11:269K                                   Electro Filings LLC/FA   
  5/6/24  Anavex Life Sciences Corp.        DEFA14A                1:2.7M                                   Electro Filings LLC/FA   
  5/6/24  Anavex Life Sciences Corp.        DEF 14A      5/6/24    1:1.8M                                   Electro Filings LLC/FA   
  4/1/24  Missling Christopher U            4          Dir.,Off.²  1:7K   Anavex Life Sciences Corp.        Electro Filings LLC/FA   
 3/28/24  Missling Christopher U            144                    1:4K   Anavex Life Sciences Corp.        Charles Schwab … Svcs/FA 
 2/23/24  Donhauser Peter D.O.              4          Director²   1:5K   Anavex Life Sciences Corp.        Electro Filings LLC/FA   
 2/23/24  Thomas Steffen                    4          Director²   1:5K   Anavex Life Sciences Corp.        Electro Filings LLC/FA   
 2/23/24  Velden Claus Vander               4          Director²   1:5K   Anavex Life Sciences Corp.        Electro Filings LLC/FA   
 2/23/24  Ma Jiong                          4          Director²   1:5K   Anavex Life Sciences Corp.        Electro Filings LLC/FA   
 2/23/24  Skarpelos Athanasios              4          Director²   1:5K   Anavex Life Sciences Corp.        Electro Filings LLC/FA   
 2/13/24  Vanguard Group Inc.               SC 13G/A               1:13K  Anavex Life Sciences Corp.        Toppan Merrill/FA        
  2/7/24  Anavex Life Sciences Corp.        10-Q       12/31/23   42:2.8M                                   Electro Filings LLC/FA   
 1/25/24  BlackRock Inc.                    SC 13G/A               1:13K  Anavex Life Sciences Corp.        Blackrock Advisors LLC   
 1/22/24  State Street Corp.                SC 13G/A               1:8K   Anavex Life Sciences Corp.                                 
 1/12/24  Missling Christopher U            4          Dir.,Off.²  1:5K   Anavex Life Sciences Corp.        Electro Filings LLC/FA   
 1/12/24  Boenisch Sandra                   4          Officer²    1:5K   Anavex Life Sciences Corp.        Electro Filings LLC/FA   
11/27/23  Anavex Life Sciences Corp.        10-K        9/30/23   54:5.7M                                   Electro Filings LLC/FA   
  8/8/23  Anavex Life Sciences Corp.        10-Q        6/30/23   39:3.1M                                   Electro Filings LLC/FA   
 6/30/23  Missling Christopher U            4          Dir.,Off.²  1:9K   Anavex Life Sciences Corp.        Electro Filings LLC/FA   
____________
 ¹  Filing/Form Types: 
Type emoji
  4    Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
  8-K    Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
  10-K    Annual Report — Form 10-K.
  10-Q    Quarterly Report — Form 10-Q.
  144    Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }.
  DEF 14A    Definitive Proxy Statement — Schedule 14A.
  DEFA14A    Definitive Additional Proxy Soliciting Material — Schedule 14A.
  SC 13G    Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
  /A  Amendment to, or Amended version of, a previous Filing of this Type.
 ²  Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
 
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   13   14   15   ...   27   ·  All     
Top



        


Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 1:38:47.6am ET